A piece of convincing evidence supporting NF-κB’s role in tumor development is that loss-of-function mutations in CYLD, which is known for its deubiquitinase activity in inhibiting NF-κB signaling, leads to spontaneous development of skin cancers. Here, NFKB1 is linked to skin neoplasm.